Literature DB >> 21820093

Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism.

Véronique Habauzit1, Sandra Maria Sacco, Angel Gil-Izquierdo, Anna Trzeciakiewicz, Christine Morand, Denis Barron, Stéphane Pinaud, Elisabeth Offord, Marie-Noëlle Horcajada.   

Abstract

The effect of hesperidin (Hp) and naringin (Nar), two major citrus flavanones, on the regulation of bone metabolism was examined in male senescent rats. Twenty -month -old gonad-intact male Wistar rats received a casein-based diet supplemented with or without either 0.5% hesperidin (Hp), 0.5% naringin (Nar) or a mix of both flavanones (Hp+Nar, 0.25% each). After 3 months, daily Hp intake significantly improved femoral bone integrity as reflected by improvements in total and regional bone mineral densities (BMD) (9.7%-12.3% improvements, p<0.05) and trabecular bone volume fraction (24.3% improvement, p<0.05) at the femur compared with control group. In contrast, naringin exerted site-specific effects on BMD (10.2% improvement at the distal metaphyseal area, p<0.05) and no further benefit to bone mass was observed with the mix of flavanones. Bone resorption (DPD) was significantly attenuated by Hp and Nar given alone (40.3% and 26.8% lower compared to control, p<0.05, respectively) but not by the mixture of the two. All treatments significantly reduced expression of inflammatory markers to a similar extent (IL-6, 81.0-87.9% reduction; NO, 34.7-39.5% reduction) compared to control. Bone formation did not appear to be strongly affected by any of the treatments (no effect on osteocalcin levels, modest modulation of tibial BMP-2 mRNA). However, as previously reported, plasma lipid-lowering effects were observed with Hp and Nar alone (34.1%-45.1% lower for total cholesterol and triglycerides compared to control, p<0.05) or together (46% lower for triglycerides, p<0.05). Surprisingly the plasma circulating level of naringin (8.15μM) was >5-fold higher than that of hesperidin (1.44μM) at equivalent doses (0.5%) and a linear reduction in plasma levels was observed upon co-administration (0.25% each) indicating absence of competition for their intestinal absorption sites and metabolism. The higher efficacy of Hp at a lower plasma concentration than naringin, as well as the identification of the major circulating metabolite of hesperidin (hesperetin-7-O-glucuronide) underlines the importance of flavanone bioavailability and metabolism in their biological efficacy and suggests a structure-function relationship in the mechanism of action of the active metabolites.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820093     DOI: 10.1016/j.bone.2011.07.030

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

Review 1.  Phytonutrients for bone health during ageing.

Authors:  Sandra Maria Sacco; Marie-Noëlle Horcajada; Elizabeth Offord
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Gender differences in plasma and urine metabolites from Sprague-Dawley rats after oral administration of normal and high doses of hydroxytyrosol, hydroxytyrosol acetate, and DOPAC.

Authors:  Raúl Domínguez-Perles; David Auñón; Federico Ferreres; Angel Gil-Izquierdo
Journal:  Eur J Nutr       Date:  2015-10-13       Impact factor: 5.614

3.  Systemic Dietary Hesperidin Modulation of Osteoclastogenesis, Bone Homeostasis and Periodontal Disease in Mice.

Authors:  Vinícius de Paiva Gonçalves; Marta Liliana Musskopf; Angeliz Rivera-Concepcion; Christina Yu; Sing Wai Wong; Stephen A Tuin; Yizu Jiao; Cristiano Susin; Luís Carlos Spolidorio; Patricia Almeida Miguez
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

4.  A novel porous gelatin composite containing naringin for bone repair.

Authors:  Kuo-Yu Chen; Kuen-Cherng Lin; Yueh-Sheng Chen; Chun-Hsu Yao
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-04       Impact factor: 2.629

5.  Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone.

Authors:  Xinlong Ma; Jianwei Lv; Xiaolei Sun; Jianxiong Ma; Guosheng Xing; Ying Wang; Lei Sun; Jianbao Wang; Fengbo Li; Yanjun Li; Zhihu Zhao
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

6.  Maternal Consumption of Hesperidin and Naringin  Flavanones Exerts Transient Effects to Tibia Bone  Structure in Female CD-1 Offspring.

Authors:  Sandra M Sacco; Caitlin Saint; Paul J LeBlanc; Wendy E Ward
Journal:  Nutrients       Date:  2017-03-08       Impact factor: 5.717

7.  Influence of Hesperidin on the Systemic and Intestinal Rat Immune Response.

Authors:  Mariona Camps-Bossacoma; Àngels Franch; Francisco J Pérez-Cano; Margarida Castell
Journal:  Nutrients       Date:  2017-06-06       Impact factor: 5.717

Review 8.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

Review 9.  Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Authors:  Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

10.  Nutritional Programming of Bone Structure in Male Offspring by Maternal Consumption of Citrus Flavanones.

Authors:  Sandra M Sacco; Caitlin Saint; Paul J LeBlanc; Wendy E Ward
Journal:  Calcif Tissue Int       Date:  2017-11-18       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.